B. Metzler Seel. Sohn & Co. Ag Regeneron Pharmaceuticals, Inc. Transaction History

B. Metzler Seel. Sohn & Co. Ag

$10 Billion
Q3 2024

A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 3,360 shares of REGN stock, worth $2.62 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,360

Previous 3,938 14.68%

Holding current value

$2.62 Million

Previous $4.14 Million 14.64%

% of portfolio

0.04%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$1024.09 - $1201.76 $591,924 - $694,617	-578 Reduced 14.68%	3,360 $3.53 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $96,268 - $116,759	109 Added 2.85%	3,938 $4.14 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $197,689 - $217,543	219 Added 6.07%	3,829 $3.69 Million
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $1.84 Million - $2.09 Million	-2,368 Reduced 39.61%	3,610 $3.17 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $377,385 - $460,181	545 Added 10.03%	5,978 $4.92 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $375,216 - $445,067	-536 Reduced 8.98%	5,433 $3.9 Million
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $1.43 Million - $1.74 Million	-2,104 Reduced 26.06%	5,969 $4.9 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $47,294 - $51,348	-67 Reduced 0.82%	8,073 $5.82 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $105,610 - $133,274	184 Added 2.31%	8,140 $5.61 Million
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $242,919 - $327,306	443 Added 5.9%	7,956 $4.7 Million
Q1 2022 May 10, 2022	BUY	$595.12 - $698.43 $576,076 - $676,080	968 Added 14.79%	7,513 $5.25 Million
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $3.56 Million - $4.39 Million	6,545 New	6,545 $4.21 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $83.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.

Account

B. Metzler Seel. Sohn & Co. Ag Regeneron Pharmaceuticals, Inc. Transaction History